biotech analyst coverage

Institutional research coverage in the biotechnology sector is undergoing a notable transformation, shaped by capital market cycles, regulatory complexity, and evolving investor expectations. As biotech companies increasingly operate at the intersection of science, policy, and commercialization, research analysts are recalibrating how they evaluate pipelines, clinical risk, and long-term value creation. This shift is redefining the … Read more